PTGER3 and cardiovascular disorder: Although the contribution of these DEGs to cardiovascular disease pathogenesis is mainly documented in humans, elevated HPGD and PTGER3 expression in dogs may amplify the effects of prostaglandins on these processes, potentially contributing to the inflammatory environment and vasodilation associated with MMVD.